Dynamic host energetics and cytoskeletal proteomes in human immunodeficiency virus type 1-infected human primary CD4 cells: analysis by multiplexed label-free mass spectrometry.
We report on a proteomic analysis of ex vivo human immunodeficiency virus (HIV) type 1 infection in human primary CD4 cells by shotgun liquid chromatography-tandem mass spectrometry analysis, revealing two distinct proteomic profiles at two phases of virus replication. Relative to mock-infected cells, 168 signature proteins exhibited abundance changes at the first sign of Gag p24 production (8 h postinfection [p.i.]) or the peak of virus replication (24 h p.i.); interestingly, most of the changes were exclusive to only one phase of virus replication. Based on characterization by functional ontology and known human-HIV protein interactions, we observed the enrichment for protein abundance increases pertaining to protein synthesis and nucleasomal reorganization amid an otherwise placid cellular proteome at the first sign of HIV replication. In contrast, we observed indications of decreased protein turnover, concomitant with heightened DNA repair activities and preludes to apoptosis, in the presence of robust virus replication. We also observed hints of disruptions in protein and small molecule trafficking. Our label-free proteomic strategy allowed us to perform multiplexed comparisons-we buttressed our detection specificity with the use of a reverse transcriptase inhibitor as a counterscreen, enabling highlighting of cellular protein abundance changes unique to robust virus replication as opposed to viral entry. In conjunction with complementary high-throughput screens for cellular partners of HIV, we put forth a model pinpointing specific rerouting of cellular biosynthetic, energetic, and trafficking pathways as HIV replication accelerates in human primary CD4 cells.
Chan
Eric Y
EY
Department of Microbiology, University of Washington, Seattle, 98195-8070, USA.
Sutton
Jennifer N
JN
Jacobs
Jon M
JM
Bondarenko
Andrey
A
Smith
Richard D
RD
Katze
Michael G
MG
D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry* / Q000821:virology*; D002478:Cells, Cultured; D002853:Chromatography, Liquid; D003598:Cytoskeletal Proteins / Q000032:analysis*; D004734:Energy Metabolism; D015658:HIV Infections / Q000473:pathology*; D015497:HIV-1; D006801:Humans; D053858:Metabolic Networks and Pathways; D021381:Protein Transport; D020543:Proteome; D040901:Proteomics / Q000379:methods; D053719:Tandem Mass Spectrometry / Q000379:methods*; D013997:Time Factors; D014779:Virus Replication
D003598:Cytoskeletal Proteins; D020543:Proteome